ArticleJournal of veterinary internal medicine
Clinicopathological findings, treatment, and outcome in 60 cats with gastrointestinal eosinophilic sclerosing fibroplasia.
Article in Journal of veterinary internal medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 18 citations in OpenAlex.
- Obstructive colonic FGESF associated with feline infectious peritonitis in a cat: a case report.BMC veterinary research · 2026Article
- A case of feline gastrointestinal eosinophilic sclerosing fibroplasia extending to the liver and jejunal lymph nodes.The Canadian veterinary journal = La revue veterinaire canadienne · 2025Article
- A Case of Feline Eosinophilic Sclerosing Fibroplasia Associated with a Duodenal Mass Responsive to Exclusive Glucocorticoid Therapy.Animals : an open access journal from MDPI · 2025Article
- Computed Tomographic Findings of Eosinophilic Enteritis in Eight Cats: Case Series.Veterinary medicine and science · 2025Article
- Feline eosinophilic sclerosing fibroplasia associated with T-/natural killer-cell lymphoma.Veterinary pathology · 2025Article
- Case Report: Multiple intra-abdominal lymph node abscesses due toFrontiers in veterinary science · 2025Article
- Nodal T-cell lymphoma with eosinophilic infiltration and sclerosing fibroplasia in a cat with eosinophilia.The Journal of veterinary medical science · 2024Article
- Feline gastrointestinal eosinophilic sclerosing fibroplasia associated with Candida albicans.Veterinary medicine and science · 2024Article
- Feline gastrointestinal eosinophilic sclerosing fibroplasia in two cats: Serial ultrasonographic and computed tomography findings.Veterinarni medicina · 2024Article
- Nasopharyngeal eosinophilic sclerosing fibroplasia in a 15-year-old cat: expanding the anatomical and age spectrum of the disease.JFMS open reportsArticle
- Bicavitary involvement of feline eosinophilic sclerosing fibroplasia with intralesional methicillin-resistantJFMS open reportsArticle
- Mediastinal eosinophilic sclerosing fibroplasia associated withJFMS open reportsArticle
- Clinicopathological findings, treatment, and outcome in 60 cats with gastrointestinal eosinophilic sclerosing fibroplasia.Journal of veterinary internal medicineArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 6 institutions in 4 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundGastrointestinal eosinophilic sclerosing fibroplasia (GESF) in cats presents as mass(es) associated with the gastrointestinal tract, mesentery, and abdominal lymph nodes. HYPOTHESIS/
objectivesTo report the clinicopathological findings, treatment, and outcome of cats with GESF. ANIMALS: Sixty client-owned cats diagnosed with GESF.
methodsRetrospective review of medical records of cats with histopathologically confirmed GESF.
resultsThe median age was 5.4 years (interquartile range [IQR], 3.3-8.9.); 30% were Domestic Shorthairs and 12% were Domestic Longhair cats, with the most prevalent pedigree breeds being Ragdolls (25%), Exotic Shorthair (10%) and Persian (8%) cats. The median duration of clinical signs was 90 days (IQR, 17.5-247.0); the most common clinical signs were weight loss (60%), hyporexia/anorexia (55%), chronic vomiting (37%), lethargy (35%) and chronic diarrhea (27%). Masses were located in the small intestine (32%), stomach (27%), ileocolic junction (15%), colon (10%), lymph node (8%) and mesentery (8%) and 15% of cats had >1 mass. Eosinophilia was present in 50% and hypoalbuminemia in 28% of cats. The mass was removed surgically in 37% of cases. Most cats (98%) were treated with corticosteroids. Survival was not statistically different between cats treated with surgical resection and cats treated with medical therapy alone, 88% of the cats were still alive at the time of writing. CONCLUSIONS AND CLINICAL IMPORTANCE: GESF is an important differential diagnosis for abdominal masses in cats, and has a much better prognosis than previously reported.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.